Dr. Ayla Kessler, MD

NPI: 1437359585
Total Payments
$11,259
2024 Payments
$196.85
Companies
47
Transactions
462
Medicare Patients
1,566
Medicare Billing
$205,608

Payment Breakdown by Category

Food & Beverage$7,147 (63.5%)
Consulting$2,650 (23.5%)
Travel$1,042 (9.3%)
Education$420.15 (3.7%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $7,147 447 63.5%
Consulting Fee $2,650 1 23.5%
Travel and Lodging $1,042 3 9.3%
Education $420.15 11 3.7%

Top Paying Companies

Company Total Records Latest Year
PFIZER INC. $4,249 33 $0 (2019)
E.R. Squibb & Sons, L.L.C. $1,241 83 $0 (2022)
Novartis Pharmaceuticals Corporation $1,111 67 $0 (2024)
Genentech USA, Inc. $538.96 33 $0 (2019)
Merck Sharp & Dohme Corporation $510.85 38 $0 (2020)
AstraZeneca Pharmaceuticals LP $391.66 24 $0 (2020)
Janssen Biotech, Inc. $323.97 21 $0 (2020)
Celgene Corporation $254.03 16 $0 (2024)
Lilly USA, LLC $240.90 13 $0 (2021)
Incyte Corporation $193.71 11 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $196.85 9 Bayer Healthcare Pharmaceuticals Inc. ($52.87)
2022 $178.90 3 Seagen Inc. ($99.99)
2021 $285.15 12 E.R. Squibb & Sons, L.L.C. ($180.68)
2020 $536.80 35 E.R. Squibb & Sons, L.L.C. ($110.79)
2019 $2,227 146 E.R. Squibb & Sons, L.L.C. ($533.18)
2018 $6,059 141 PFIZER INC. ($3,963)
2017 $1,775 116 Genentech USA, Inc. ($306.32)

All Payment Transactions

462 individual payment records from CMS Open Payments — Page 1 of 19

Date Company Product Nature Form Amount Type
12/02/2024 Celgene Corporation REBLOZYL (Biological) Food and Beverage Cash or cash equivalent $14.65 General
Category: Hematology
11/19/2024 Novartis Pharmaceuticals Corporation Fabhalta (Drug) Food and Beverage In-kind items and services $19.95 General
Category: Immunology
11/04/2024 Incyte Corporation JAKAFI (Drug) Food and Beverage Cash or cash equivalent $27.66 General
Category: Hematology/Oncology
10/08/2024 ARRAY BIOPHARMA INC BRAFTOVI (Drug), MEKTOVI Food and Beverage In-kind items and services $20.85 General
Category: ONCOLOGY
09/25/2024 Celgene Corporation REBLOZYL (Biological) Food and Beverage Cash or cash equivalent $14.19 General
Category: Hematology
09/17/2024 Incyte Corporation JAKAFI (Drug) Food and Beverage Cash or cash equivalent $23.50 General
Category: Hematology/Oncology
09/09/2024 Bayer Healthcare Pharmaceuticals Inc. Nubeqa (Drug) Food and Beverage In-kind items and services $23.91 General
Category: Oncology
07/10/2024 Novartis Pharmaceuticals Corporation KISQALI (Drug) Food and Beverage In-kind items and services $23.18 General
Category: Oncology
06/05/2024 Bayer Healthcare Pharmaceuticals Inc. Nubeqa (Drug) Food and Beverage In-kind items and services $28.96 General
Category: Oncology
10/14/2022 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Food and Beverage Cash or cash equivalent $29.70 General
Category: Oncology
09/14/2022 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Food and Beverage Cash or cash equivalent $49.21 General
Category: Oncology
07/07/2022 Seagen Inc. Education In-kind items and services $99.99 General
11/09/2021 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Food and Beverage Cash or cash equivalent $7.65 General
Category: Oncology
11/09/2021 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Food and Beverage Cash or cash equivalent $2.18 General
Category: Oncology
10/21/2021 Lilly USA, LLC VERZENIO (Drug) Education In-kind items and services $69.44 General
Category: Oncology
09/16/2021 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Food and Beverage Cash or cash equivalent $122.27 General
Category: Oncology
07/28/2021 Epizyme, Inc., TAZVERIK (Drug) Education In-kind items and services $11.50 General
Category: ONCOLOGY
06/01/2021 Gilead Sciences, Inc. Education In-kind items and services $11.92 General
05/27/2021 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Education In-kind items and services $10.70 General
Category: Oncology
05/17/2021 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Food and Beverage Cash or cash equivalent $5.26 General
Category: Oncology
05/17/2021 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Food and Beverage Cash or cash equivalent $2.38 General
Category: Oncology
03/23/2021 JAZZ PHARMACEUTICALS INC. ZEPZELCA (Drug) Education In-kind items and services $11.61 General
Category: HEMATOLOGY/ONCOLOGY
03/18/2021 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Education In-kind items and services $11.04 General
Category: Oncology
02/10/2021 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Food and Beverage Cash or cash equivalent $19.20 General
Category: Oncology
09/16/2020 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Food and Beverage Cash or cash equivalent $21.24 General
Category: Oncology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 4 115 150 $34,228 $11,270
2022 6 403 602 $109,148 $42,453
2021 6 552 917 $172,475 $74,376
2020 6 496 1,012 $171,130 $77,509
Total Patients
1,566
Total Services
2,681
Medicare Billing
$205,608
Procedure Codes
25

All Medicare Procedures & Services

25 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2023 36 47 $15,392 $4,899 31.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 31 41 $9,363 $2,947 31.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2023 33 44 $6,427 $2,115 32.9%
99443 Telephone medical discussion with physician, 21-30 minutes Facility 2023 15 18 $3,046 $1,309 43.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 131 263 $47,485 $18,412 38.8%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2022 57 97 $24,751 $10,409 42.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2022 144 171 $21,742 $7,192 33.1%
99204 New patient office or other outpatient visit, 45-59 minutes Facility 2022 29 29 $6,769 $2,758 40.7%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2022 15 15 $4,350 $2,159 49.6%
99203 New patient office or other outpatient visit, 30-44 minutes Facility 2022 27 27 $4,051 $1,523 37.6%
99215 Established patient outpatient visit, total time 40-54 minutes Facility 2021 139 311 $71,547 $31,298 43.7%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 160 311 $54,522 $23,146 42.5%
99213 Established patient outpatient visit, total time 20-29 minutes Facility 2021 153 195 $23,924 $9,403 39.3%
99205 New patient outpatient visit, total time 60-74 minutes Facility 2021 35 35 $9,625 $4,605 47.8%
99204 New patient outpatient visit, total time 45-59 minutes Facility 2021 40 40 $9,174 $4,306 46.9%
99203 New patient outpatient visit, total time 30-44 minutes Facility 2021 25 25 $3,683 $1,617 43.9%
99215 Established patient office or other outpatient, visit typically 40 minutes Facility 2020 179 584 $108,810 $48,074 44.2%
99215 Established patient office or other outpatient, visit typically 40 minutes Office 2020 43 61 $11,529 $6,901 59.9%
99214 Established patient office or other outpatient, visit typically 25 minutes Facility 2020 83 108 $15,182 $5,657 37.3%
99205 New patient office or other outpatient visit, typically 60 minutes Facility 2020 37 37 $9,971 $4,748 47.6%
99213 Established patient office or other outpatient visit, typically 15 minutes Facility 2020 86 137 $12,722 $4,547 35.7%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2020 16 17 $4,550 $2,760 60.7%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2020 12 23 $3,224 $1,933 60.0%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 18 19 $2,698 $1,467 54.4%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 22 26 $2,444 $1,422 58.2%

About Dr. Ayla Kessler, MD

Dr. Ayla Kessler, MD is a Internal Medicine healthcare provider based in Jefferson, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2007. The National Provider Identifier (NPI) number assigned to this provider is 1437359585.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ayla Kessler, MD has received a total of $11,259 in payments from pharmaceutical and medical device companies, with $196.85 received in 2024. These payments were reported across 462 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($7,147).

As a Medicare-enrolled provider, Kessler has provided services to 1,566 Medicare beneficiaries, totaling 2,681 services with total Medicare billing of $205,608. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Internal Medicine, Hematology
  • Location Jefferson, NC
  • Active Since 07/18/2007
  • Last Updated 03/14/2024
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1437359585

Products in Payments

  • IBRANCE (Drug) $4,053
  • OPDIVO (Biological) $886.64
  • KEYTRUDA (Biological) $481.85
  • KISQALI (Drug) $392.25
  • JAKAFI (Drug) $193.71
  • EMPLICITI (Biological) $151.44
  • DARZALEX (Biological) $143.81
  • Perjeta (Biological) $137.56
  • MEKINIST (Drug) $136.11
  • XTANDI (Drug) $135.82
  • Cabometyx (Drug) $124.78
  • VOTRIENT (Drug) $116.04
  • Lenvima (Drug) $112.37
  • TECENTRIQ (Biological) $110.43
  • Revlimid (Drug) $109.11
  • JADENU (Drug) $106.50
  • LYNPARZA (Drug) $102.98
  • ZYTIGA (Drug) $99.43
  • SPRYCEL (Drug) $97.72
  • SANDOSTATIN LAR (Drug) $93.30

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Jefferson